PharmaZell GmbH completed the acquisition of Groupe Novasep SAS from BlackRock, Inc. and Silver Point Capital L.P.
Rothschild & Co SCA acted as financial advisor, Marc Castagnede, Romy Richter, Guillaume Valois, Guillaume Auzanneau, Arthur Sauzay, Gabrielle Nivet, Marianne Delassaussé, Luc Lamblin, Olivier Picquerey, Hovig Cancioglu of Allen & Overy France, Nils Koffka, Roman Kasten, Hannah Wohlfarth, Udo Olgemöller, Sebastian Schulz, Jürgen Schindler, Robin Harvey, Nihaal Khanna, Matthew Appleton, Jules Lecoeur, Emma Fata, Charles-Hugo Lerebour, Eda Zhuleku, Kenneth Rivlin, Richard Qiang, Chaohui Liang, Matt Huggett, Matthew Townsend, Tim Müller and Sebastian Schulz of Allen & Overy LLP, Sarah-Jayne Mackin and Laura Campbell of Allen & Overy (SSF) Limited acted as legal advisor and Ernst & Young LLP acted as accountant to PharmaZell GmbH. Jefferies Financial Group Inc. acted as financial advisor, Cleary Gottlieb Steen & Hamilton LLP acted as legal advisor and Ernst & Young LLP acted as accountant to Groupe Novasep SAS. Rabindra Jhunjhunwala, Roshnek Dhalla of Khaitan & co advised Allen & Overy LLP as legal advisor.
PharmaZell GmbH completed the acquisition of Groupe Novasep SAS from BlackRock, Inc. (NYSE:BLK) and Silver Point Capital L.P. on April 7, 2022.